Basic Search
|
Geographic Searches
|
Advanced Search |
MegadealsSubsidy Tracker: Industry Summary Page
Major Industry: pharmaceuticals
Subsidy Total: $3,972,211,621
Number of Awards: 2,783
Time Period: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2012.
Notes: The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.
Top 10 Parent Companies | Total Subsidy $ | Number of Awards |
Eli Lilly | $601,741,368 | 77 |
Regeneron Pharmaceuticals | $469,433,071 | 112 |
AstraZeneca | $436,175,713 | 52 |
Pfizer | $332,313,011 | 206 |
Novo Holdings A/S | $241,475,902 | 102 |
Elanco Animal Health | $189,545,200 | 7 |
Merck | $153,889,367 | 82 |
AbbVie | $145,729,008 | 68 |
Johnson & Johnson | $111,279,431 | 124 |
Bristol-Myers Squibb | $110,616,473 | 81 |
Individual Subsidy Records:
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. | Sanofi | New Jersey | state | 2005 | $8,369,000 | | grant |
Pharmacia Corporation, Affiliates and Subsidiaries | Pfizer | New Jersey | state | 2001 | $8,752,000 | | grant |
Pfizer Inc. | Pfizer | New Jersey | state | 2010 | $9,182,250 | | grant |
Pharmacia & Upjohn Company | Pfizer | New Jersey | state | 1998 | $12,500,000 | | grant |
Allergan Sales, LLC | AbbVie | New Jersey | state | 2011 | $14,906,273 | | grant |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. In | Sanofi | New Jersey | state | 1999 | $21,795,200 | | grant |
ImClone Systems Corporation | Eli Lilly | New Jersey | state | 2008 | $32,363,676 | | grant |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2012 | $627,519 | | property tax abatement |
Merck Animal Health | Merck | Louisiana | state | 2012 | $995,624 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2012 | $409,319 | | property tax abatement |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $2,611 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $3,872 | | tax credit/rebate |
AXIS SHIELD DIAGNOSTICS LIMITED | Abbott Laboratories | Washington | state | 2011 | $4,930 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $12,368 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
PROFIBRIX INC | Novartis | Washington | state | 2011 | $28,045 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $60,285 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $83,248 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $181,239 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $207,108 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2011 | $11,724 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $19,669 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2011 | $33,727 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2011 | $42,682 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $91,754 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $106,749 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $143,394 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2011 | $3,568,422 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Connecticut | state | 2012 | $51,000,000 | | tax credit/rebate |
Ventana Medical Systems | Roche | Arizona | state | 2003 | $585,765 | | training reimbursement |
Abbott Laboratories, Ross Products Div | Abbott Laboratories | Arizona | state | 2004 | $235,647 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2005 | $443,248 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $129,073 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $454,796 | | training reimbursement |
Abraxis BioScience, Inc. | Bristol-Myers Squibb | Arizona | state | 2009 | $279,390 | | training reimbursement |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $253,000 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $22,005 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2004 | $581,065 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2005 | $581,065 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $375,100 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2006 | $397,686 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2006 | $72,042 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2006 | $485,991 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $380,245 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2007 | $116,504 | | tax credit/rebate |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $1,375 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2007 | $3,626,627 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2007 | $518,618 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2008 | $10,777 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2008 | $25,745 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2008 | $474,786 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2008 | $3,658,748 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2009 | $10,777 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2009 | $25,745 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2009 | $99,581 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $156,516 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $351,337 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2009 | $3,626,627 | | tax credit/rebate |
MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2010 | $10,777 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2010 | $19,669 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2010 | $25,745 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $51,253 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2010 | $91,754 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $99,581 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $143,394 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $298,738 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2010 | $3,568,422 | | tax credit/rebate |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | $250,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $695,000 | | grant |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2008 | $47,957 | | grant |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2008 | $20,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2009 | $414,661 | | grant |
BEN VENUE LABORATORIES INC | Boehringer Ingelheim | Ohio | state | 2009 | $45,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $300,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2012 | $45,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2010 | $31,792 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2010 | $138,219 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2011 | $55,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $1,380,000 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2012 | $195,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2013 | $150,000 | | grant |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | $879,466 | | tax credit/rebate |
PBM Covington, LLC | Perrigo | Ohio | state | 2009 | $339,354 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2012 | $5,369,069 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $45,000 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $49,500 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $85,700 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $91,500 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $347,213 | | tax credit/rebate |
Mallinckrodt Enterprises | Mallinckrodt | North Carolina | state | 2012 | $441,576 | | tax credit/rebate |